TLS:ASXTelstra Group Limited Analysis
Data as of 2026-07-30 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Telstra (TLS) is trading at AUD 5.06, just above its 200‑day SMA (5.06) and slightly below the 50‑day SMA (5.09), indicating a neutral technical stance. The RSI sits at 53, suggesting neither over‑bought nor over‑sold conditions, while the MACD histogram is modestly positive, giving a faint bullish signal. Price action is bounded by a clear support level around 4.80 and resistance near 5.10, with volume trending upward, which adds short‑term liquidity confidence. Fundamentally, the stock commands a PE of 25.3 versus an industry average of 15.9, and a P/B of 4.31, pointing to a premium valuation that is not fully justified by its modest 0.3% revenue growth and flat EPS outlook. The dividend yield of 4.15% is attractive, but the payout ratio of roughly 96% raises concerns about sustainability, especially given a high debt‑to‑equity ratio of 119% and total debt of AUD 18.75 bn. Operating cash flow remains robust (AUD 7.8 bn) and free cash flow is healthy (AUD 3.9 bn), yet the balance sheet leverage and limited growth tilt the risk‑reward balance toward caution. The 30‑day volatility of about 20% and an almost neutral beta (‑0.01) suggest price swings are driven more by company‑specific factors than market movements. Recent news highlights Telstra’s defensive profile and dividend appeal, reinforcing its perception as a “defensive dividend” play but offering little new catalyst for upside. Overall, the stock appears slightly overvalued, with defensive merits offset by valuation pressure and leverage concerns.
Market Outlook
Short Term
< 1 yearKey Factors
- Price near short‑term resistance with modest bullish MACD
- Strong dividend yield but high payout ratio
- Increasing volume supporting liquidity
Medium Term
1–3 yearsKey Factors
- Valuation premium relative to peers
- Robust operating cash flow offset by high debt load
- Limited revenue growth and flat EPS guidance
Long Term
> 3 yearsKey Factors
- Significant overvaluation versus DCF fair value
- Elevated leverage and debt‑to‑equity ratio
- Unsustainable dividend payout in a low‑growth environment
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.